Endocrine Disruption Screening Market Scope And Analysis

  • Report Code : TIPRE00025912
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 226
Buy Now

Endocrine Disruption Screening Market Analysis Report 2031

Buy Now


Endocrine Disruption Screening Market Report Scope

Report Attribute Details
Market size in 2021 US$ 126.53 Million
Market Size by 2028 US$ 153.30 Million
Global CAGR (2021 - 2028) 2.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Assay Type
  • In-Vitro and In-Vivo
By Application
  • Natural Materials and Synthetic Materials
By Sources of Waste
  • Incineration and Landfill
  • Agricultural Runoff
  • Industrial and Municipal Effluents
  • Pulp Mill Effluents
  • Consumer Products
By Method
  • Estrogen Receptor Transactivation
  • Androgen Receptor Transactivation
  • Androgen Receptor Modulation
  • Estrogen Receptor-Alpha Binding
  • Estrogen Receptor-Beta Binding
  • Androgen Receptor Binding
  • Steroidogenesis
  • Aromatase Assay
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • CREATIVE BIOARRAY
  • XENOMETRIX AG
  • CHARLES RIVER
  • EUROFINS SCIENTIFIC
  • SMITHERS
  • SGS SA
  • JRF GLOBAL
  • M RIEUX NUTRISCIENCES
  • ALPHA ANALYTICAL